The R&D Graduate Scheme is a 2-year early talent program comprising of 3 individual 8-month placements across the R&D organisation with the aim of providing a broad exposure to multiple areas of cutting-edge scientific research and drug development. Through development modules in collaboration with the Oxford Group the program also enhances professional and personal development.Rotation 3 - Study ManagementWorking within the global study team to coordinate all start up activities and procedures needed to start a Phase 2 study. Responsible for authoring of study specific documents, third party vendor management, clinical trial applications and more to ensure study delivery according to timelines.Rotation 2 - Clinical DevelopmentI contributed to clinical development within the field of Respiratory and Immunolog. Here, I gained experience within project management as well as hands on experience of driving a drug project in Phase 1.Rotation 1 - Translational GenomicsWithin the precision genome editing team I was working on assay development for CRISPR technologies.

At iGEM Chalmers Gothenburg I were taking part in the wet lab work, fundraising, outreach and manage the social media accounts . iGEM is the largest annual synthetic biology research competition in the world. Participating teams try to solve problems of the modern world using the tools of synthetic biology. Our team of 2017, focused on developing a biosensor for detection of lung cancer at an early stage of the disease.

My tasks as a process operator included various tasks in the conversion of consumer products. As part of a shift, I have learned to work together with a team and solve problems in a group